IP Library Granted Patent US 9,988,417
Granted Patent B2
US 9,988,417 · App. 15/022,177 · Granted Jun 5, 2018

Process for the preparation of estetrol

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,988,417
App. No.
15/022,177
Granted
Jun 5, 2018
Kind
B2
Abstract

The invention relates to a process for obtaining Estetrol or a salt or solvate thereof, the process comprising: a) reacting a compound of formula (IV) or a salt or solvate thereof, wherein R 1 is a hydroxyl protecting group selected from a silyl ether, an ether, an ester, a carbamate and a carbonate, and R 2 is a hydroxyl protecting group selected from an ether, with an oxidizing agent selected from OsO 4 or a source of osmium tetroxide to produce Estetrol or a compound of formula (II) or a salt or solvate thereof wherein R 1 is as defined previously; and b) if a compound of formula (II) is obtained in step a), deprotecting said compound to produce Estetrol.

Claims (30)

1. A compound of formula (IV)

or a salt or solvate thereof, wherein

R 1 O is a protected hydroxyl group selected from the group consisting of a silyl ether, an ether, an ester, a carbamate and a carbonate,

R 2 O is a protected hydroxyl group which is an ether,

with the proviso that the ether in R 2 O does not include silyl ether;

with the proviso that if R 1 O is a methyl ether, then R 2 O is neither a 2-propynyl ether nor a 2- tetrahydropyranyl ether.

2. A compound, according to claim 1 , selected from

or a salt or solvate thereof.

3. A process for the preparation of Estetrol or a salt or solvate thereof, the process comprising:

a) reacting a compound of formula (IV)

or a salt or solvate thereof, wherein

R 1 O at position C3 is a protected hydroxyl group selected from the group consisting of a silyl ether, an ether, an ester, a carbamate and a carbonate,

R 2 O at position C17 is a protected hydroxyl group which is an ether,

with the proviso that the ether in R 2 O does not include silyl ether;

with an oxidizing agent selected from OsO 4 or a source of osmium tetroxide to produce Estetrol or a compound of formula (II) or a salt or solvate thereof

wherein R 1 is as defined previously; and

b) if a compound of formula (II) is obtained in step a), deprotecting said compound to produce Estetrol.

4. The process according to claim 3 , wherein the oxidizing agent is supported.

5. The process according to claim 3 , wherein the oxidizing agent is OsO 4 -PVP (poly(4-vinyl-pyridine)).

6. The process according to claim 3 , wherein a co-oxidant is further added.

7. The process according to claim 3 , wherein trimethylamine-N-oxide is added as co-oxidant.

8. The process according to claim 3 , wherein the 15β,16β-diol isomer is obtained in an amount ≤3% with respect to the sum of 15β,16β-diol and 15α,16α-diol.

9. The process according to claim 3 , wherein the protected hydroxyl group at position C17 in the compound of formula (IV) is an ether selected from (1-butoxyethyl) ether, tetrahydropyranyl (THP) ether, phenylthiomethyl (PTM) ether, and methoxymethyl (MOM) ether.

10. The process according to claim 3 , wherein the protected hydroxyl group at position C3 in the compound of formula (IV) is an ester.

11. The process according to claim 3 , wherein the protected hydroxyl group at position C3 in the compound of formula (IV) is a benzoyl ester.

12. The process according to claim 3 , wherein the protected hydroxyl group at position C3 in the compound of formula (IV) is a benzoyl ester and the protected hydroxyl group at C17 is a (1-butoxyethyl) ether.

13. The process according to claim 3 , wherein the protected hydroxyl group at position C3 in the compound of formula (IV) is an ether.

14. The process according to claim 13 , wherein the protected hydroxyl group at position C3 in the compound of formula (IV) is an ether selected from (1-butoxyethyl) ether, tetrahydropyranyl (THP) ether, phenylthiomethyl (PTM) ether, and methoxymethyl (MOM) ether.

15. The process according to claim 13 , wherein the protected hydroxyl groups at positions C3 and C17 are each an ether independently selected from the group consisting of an alkoxy or aryloxy alkyl ether or an alkyl or aryl thioalkyl ether.

16. The process according to claim 15 , wherein the protected hydroxyl groups at positions C3 and C17 are each methoxymethyl (MOM) ether or tetrahydropyranyl (THP) ether.

Assignments (2)
CHANGE OF NAME Recorded Nov 5, 2025
From: CRYSTAL PHARMA, S.A.U.
To: CURIA SPAIN, S.A.U.
Reel/Frame 073449/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2016
From: FERREIRO GIL, JUAN JOSÉ; IGLESIAS RETUERTO, JESÚS MIGUEL
To: CRYSTAL PHARMA, S.A.U.
Reel/Frame 037990/0418 →